Previous close | 474.85 |
Open | 474.85 |
Bid | 451.15 |
Ask | 458.40 |
Strike | 280.00 |
Expiry date | 2024-06-21 |
Day's range | 474.85 - 474.85 |
Contract range | N/A |
Volume | |
Open interest | 6 |
Nvidia and several other leaders flashed buy signals as the market roared. Investors should take advantage, but it's a jungle out there.
ResMed stock jumped Friday after crushing sales estimates and wiping out worries that weight-loss drugs would squeeze sleep apnea device sales.
Lilly is soon planning to ask global regulators to approve tirzepatide for sleep apnea treatment. Is Eli Lilly stock a buy?